Patent ID: 11911361
Assignee: RADIUS PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of treating Prader-Willi syndrome in a subject in need of such treatment, comprising administering to the subject an effective amount of an oral pharmaceutical formulation consisting of:
from about 8% to about 32% w/w cannabidiol;
caprylic/capric triglyceride at a concentration of 58 to 90% w/w;
alpha tocopherol at a concentration of from 0.01 to 1% w/w;
a sweetener at a concentration of 0.01 to 2% w/w; and
a flavoring agent at a concentration of 0.01 to about 1% w/w,, wherein w/w denotes weight by weight of the formulation, and wherein the effective amount results in administration of from about 20 to about 40 milligrams of cannabidiol per kilogram body weight of the subject per day, and wherein the subject is a human subject.